UTAH MEDICAL PRODUCTS INC — Form 10-Q
Filed August 12, 2026 · analyzed by the Periodic Agent
10-Q
— Neutral
significance 3/100
What the filing says
CEO Kevin L. Cornwell and CFO Brian L. Koopman certified the 10-Q for period ending June 30, 2026 (filed August 12, 2026) pursuant to SOX Sections 302 and 906. Both officers attested that financial statements fairly present the company's condition, that disclosure controls are effective, and no material weaknesses or fraud involving management were identified.
Why this rating
Routine SOX certification boilerplate; no substantive business events, financial figures, or changes disclosed. Standard periodic compliance filing.
See more from August 12, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.